P. White

发表

Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice.

P. White, P. Delaney, R. Fogarty, 1999, The Journal of investigative dermatology.

Antisense oligonucleotides in cutaneous therapy.

P. White, C. Wraight, P. White, 2001, Pharmacology & therapeutics.

Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia

A. T. Nguyen, P. White, P. Sexton, 2021, Nature.

Enhanced extravasation, stability and in vivo cardiac gene silencing via in situ siRNA-albumin conjugation.

P. White, C. Pouton, B. Boyd, 2012, Molecular pharmaceutics.

Use of Kv1.3 blockers for inflammatory skin conditions.

D. Manallack, P. White, H. Wulff, 2010, Current medicinal chemistry.

Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation

K. Gregory, P. White, A. Christopoulos, 2016, The Journal of Pharmacology and Experimental Therapeutics.

The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implications.

P. White, L. May, E. A. Vecchio, 2019, Pharmacology & therapeutics.

Oligonucleotide uptake in cultured keratinocytes: influence of confluence, cationic liposomes, and keratinocyte cell type.

P. White, R. Fogarty, S. McKean, 1999, The Journal of investigative dermatology.

Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides

P. White, R. Fogarty, S. McKean, 2000, Nature Biotechnology.

Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonism

Joanne Baltos, P. White, A. Christopoulos, 2017, Biochemical pharmacology.

Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis

P. White, L. May, E. A. Vecchio, 2017, Front. Pharmacol..

Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist

Joanne Baltos, P. White, P. Sexton, 2014, Proceedings of the National Academy of Sciences.

Interaction of viruses with host cell molecular motors.

P. White, C. Pouton, Ming Je Hsieh, 2010, Current opinion in biotechnology.

Synthesis and evaluation of new N6-substituted adenosine-5'-N-methylcarboxamides as A3 adenosine receptor agonists.

Shane M. Devine, P. White, S. Bottle, 2010, Bioorganic & medicinal chemistry.

Edaravone containing isoindoline nitroxides for the potential treatment of cardiovascular ischaemia

P. White, S. Bottle, P. Scammells, 2011 .

Targeting G protein‐coupled receptors for heart failure treatment

A. T. Nguyen, L. May, R. Ritchie, 2023, British journal of pharmacology.

The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.

Joanne Baltos, P. White, A. Christopoulos, 2016, Biochemical pharmacology.

Cooperative Cardioprotection Through Adenosine A1 and A2A Receptor Agonism in Ischemia-Reperfused Isolated Mouse Heart

P. White, C. Ledent, C. Pouton, 2010, Journal of cardiovascular pharmacology.

Cardioprotection Induced by Adenosine A1 Receptor Agonists in a Cardiac Cell Ischemia Model Involves Cooperative Activation of Adenosine A2A and A2B Receptors by Endogenous Adenosine

P. White, C. Pouton, I. Coupar, 2009, Journal of cardiovascular pharmacology.

BARRIERS TO SUCCESSFUL DELIVERY OF SHORT INTERFERING RNA AFTER SYSTEMIC ADMINISTRATION

P. White, P. White, 2008, Clinical and experimental pharmacology & physiology.

Intravenous Insulin-like Growth Factor-I Receptor Antisense Treatment Reduces Angiotensin Receptor Expression and Function in Spontaneously Hypertensive Rats

P. White, J. Short, Nga Cao, 2006, Journal of Pharmacology and Experimental Therapeutics.

Intravenous IGF‐I receptor antisense reduces IGF‐IR expression and diminishes pressor responses to angiotensin II in conscious normotensive rats

P. White, T. Nguyen, P. White, 2005, British journal of pharmacology.

Sequence dependence of C5-propynyl-dU,dC-phosphorothioate oligonucleotide inhibition of the human IGF-I receptor: mRNA, protein, and cell growth.

P. White, R. Fogarty, S. McKean, 2002, Antisense & nucleic acid drug development.

Comparison of opioid receptor distributions in the rat central nervous system.

P. White, A. C. Gray, I. Coupar, 2006, Life sciences.

Biased agonism at adenosine receptors.

Joanne Baltos, P. White, L. May, 2021, Cellular signalling.

An Allosteric Modulator of the Adenosine A1 Receptor Improves Cardiac Function Following Ischaemia in Murine Isolated Hearts

Shane M. Devine, P. White, A. Butcher, 2013, Pharmaceuticals.

A Novel Highly Selective Adenosine A1 Receptor Agonist VCP28 Reduces Ischemia Injury in a Cardiac Cell Line and Ischemia–Reperfusion Injury in Isolated Rat Hearts at Concentrations That Do Not Affect Heart Rate

Shane M. Devine, P. White, C. Pouton, 2010, Journal of cardiovascular pharmacology.

A suicidal strain of Listeria monocytogenes is effective as a DNA vaccine delivery system for oral administration.

P. White, Cheng-Yi Kuo, C. Pouton, 2017, Vaccine.

Pharmacological Insights Into Safety and Efficacy Determinants for the Development of Adenosine Receptor Biased Agonists in the Treatment of Heart Failure

C. Langmead, P. White, P. Sexton, 2020, bioRxiv.

HCN channelopathy and cardiac electrophysiologic dysfunction in genetic and acquired rat epilepsy models

D. Pinault, C. Reid, P. White, 2014, Epilepsia.

Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides

P. White, C. Pouton, B. Boyd, 2009, Expert Reviews in Molecular Medicine.

Synthesis of six mexiletine derivatives with isoindolines attached as potential antioxidants and their evaluation as cardioprotective agents

W. R. Jackson, P. White, C. Wright, 2015 .

The role of the adenosine system in epilepsy and its comorbidities

Pablo M. Casillas-Espinosa, P. Kwan, Joanne Baltos, 2023, British journal of pharmacology.

Effect of the 5-HT4 receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract

P. White, H. Irving, I. Coupar, 2018, BMC Research Notes.